Bellerophon Therapeutics BLPH
$ 0.1
-74.18%
Quarterly report 2023-Q3
added 11-14-2023
Bellerophon Therapeutics Cash Flow 2011-2024 | BLPH
Annual Cash Flow Bellerophon Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.8 M | -22.8 M | -19.9 M | -12.9 M | -15.5 M | -15.9 M | -17.2 M | -46.3 M | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
1.23 M | 1.19 M | 3.72 M | 3.11 M | 2.76 M | 3.85 M | 2.81 M | 1.61 M | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Bellerophon Therapeutics
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 3.27 M | - | -13.4 M | -8.41 M | -4.74 M | - | -18.8 M | -13.3 M | -7.89 M | - | -13.5 M | -8.56 M | -4.34 M | - | -10 M | -6.08 M | -2.34 M | - | -11.4 M | -6.06 M | -444 K | - | -11.4 M | -8.17 M | -3.66 M | - | - | - | - | - | -29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
612 K | 1.89 M | 1.07 M | 1.23 M | 1.52 M | 2.01 M | 2.19 M | 1.19 M | 1.28 M | 2.48 M | 3.81 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M | 3.11 M | 3.11 M | 3.11 M | 3.11 M | 2.76 M | 2.76 M | 2.76 M | 2.76 M | 3.85 M | 3.85 M | 3.85 M | 3.85 M | 2.81 M | 2.81 M | 2.81 M | 2.81 M | 1.61 M | 1.61 M | 1.61 M | 1.61 M | 376 K | 376 K | 376 K | 376 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency